Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Private Equity Firm
Pharma
Bavarian Nordic confirms buyout talks
Bavarian Nordic, maker of the chikungunya vaccine Vimkunya, is in talks with private equity firms Nordic Capital and Permira about a potential takeover.
Angus Liu
Jul 24, 2025 11:13am
Manufacturer PCI snares 'sizable' private equity investment
Jul 15, 2025 8:30am
Bluebird investor reluctance pays off with better buyout offer
May 14, 2025 10:40am
Bluebird warns of potential bankruptcy amid buyout delay
May 13, 2025 9:56am
Bain Capital lays out $3.3B to acquire Mitsubishi Tanabe Pharma
Feb 7, 2025 11:26am
Grifols deflects private equity firm's potential takeover offer
Nov 20, 2024 10:13am
